BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9431881)

  • 21. New thoughts in exploring the pathogenesis, diagnosis, and treatment of threatened abortion.
    Zhou J; Huang Z; Pan X; Leung WT; Li C; Chen L; Zhang Y; Wang L; Sima Y; Zhang N; Qiu X; Li L; Wang L
    Biosci Trends; 2019; 13(3):284-285. PubMed ID: 31327799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the outcome of pregnancy in threatened abortion by biochemical methods.
    Karjalainen O; Stenman U; Wichmann K; Widholm O
    Ann Chir Gynaecol Fenn; 1974; 63(6):457-64. PubMed ID: 4140705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of serum biomarkers in the prediction of outcome in women with threatened miscarriage: a systematic review and diagnostic accuracy meta-analysis.
    Pillai RN; Konje JC; Tincello DG; Potdar N
    Hum Reprod Update; 2016; 22(2):228-39. PubMed ID: 26663220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of traditional Chinese medicine treatment on levels of blocking antibody, beta-hCG, progesterone and estradiol in spontaneous abortion].
    Gui SQ; Xu J; Yu EK
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Nov; 17(11):645-8. PubMed ID: 10322841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiating tubal abortion from viable ectopic pregnancy with serum CA-125 and beta-human chorionic gonadotropin determinations.
    Predanic M
    Fertil Steril; 2000 Mar; 73(3):522-5. PubMed ID: 10689006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of hormone determinations in the first half of pregnancy.
    Gerhard I; Runnebaum B
    Eur J Obstet Gynecol Reprod Biol; 1984 Apr; 17(1):1-17. PubMed ID: 6203784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognosis and treatment of threatened abortion. A. Prognostic value of maternal serum determination of choriogonadotropin and its free alpha and beta subunits in threatened abortion of the first trimester: correlation with ultrasonographic examination].
    Gaspard U; Schaaps JP; Piront F; Deville JL; Reuter AM; Vrindts-Gevaert Y; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1980; 9(1):62-6. PubMed ID: 7451883
    [No Abstract]   [Full Text] [Related]  

  • 28. Progesterone and human chorionic gonadotrophin in serum and pregnandiol in urine in threatened abortion.
    Hertz JB; Larsen JF; Arends J; Nielsen J
    Acta Obstet Gynecol Scand; 1980; 59(1):23-7. PubMed ID: 7386186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Endocrine changes following progesterone substitution in early pregnancy].
    Vytiska-Binstorfer E; Binder K; Huber J; Spona J
    Z Geburtshilfe Perinatol; 1986; 190(4):146-8. PubMed ID: 2429465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Proceedings: Prognosis in threatened abortion and chorionic hormone levels in the blood].
    Medoki N; Kurakata H; Uehara K; Saito S; Nakayama T
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):520. PubMed ID: 4476544
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of the prognosis of threatened abortion from the peripheral plasma levels of progesterone, estradiol, and human chorionic gonadotropin.
    Nygren KG; Johansson ED; Wide L
    Am J Obstet Gynecol; 1973 Aug; 116(7):916-22. PubMed ID: 4736953
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prognostic reliability of a single study of plasma values of 17-beta estradiol, progesterone and human choriogonadotropin in threatened pregnancy in the 1st trimester].
    Jirous J; Jirkalová V; Lacinová V; Kafka P; Malírová E
    Bratisl Lek Listy; 1988 Apr; 89(4):270-5. PubMed ID: 3395873
    [No Abstract]   [Full Text] [Related]  

  • 33. [The prognostic value of serum hCG analysis with the aid of an HCG-receptor assay in patients with imminent abortion (proceedings)].
    Clasen C; Leidenberger FA; Pahnke VG
    Arch Gynakol; 1977 Jul; 224(1-4):89-90. PubMed ID: 579955
    [No Abstract]   [Full Text] [Related]  

  • 34. Prognosis in threatened abortion evaluated by hormone assays and ultrasound scanning.
    Eriksen PS; Philipsen T
    Obstet Gynecol; 1980 Apr; 55(4):435-8. PubMed ID: 7366899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hormonal profile in threatened abortion and its treatment with HCG].
    Desanso G; Lalario R; Cenderelli G; D'Addato F; Surico N; Visentin L
    Minerva Ginecol; 1981 May; 33(5):421-8. PubMed ID: 7254663
    [No Abstract]   [Full Text] [Related]  

  • 36. [Diagnosis of ovum viability: comparative analysis between ultrasound and chorionic gonadotropin hormone].
    Romero Gutiérrez G; Farías Gómez E; Castelazo Guemez JM
    Ginecol Obstet Mex; 1991 Aug; 59():265-8. PubMed ID: 1722479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic significance of maternal serum CA125 measurement in threatened abortion.
    Oçer F; Beşe T; Saridoğan E; Aydinli K; Atasü T
    Eur J Obstet Gynecol Reprod Biol; 1992 Sep; 46(2-3):137-42. PubMed ID: 1451890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [HCG and SP-1 in normal pregnancy and in high-risk early pregnancy].
    Vetter K; Flury G; Keller PJ
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):868-70. PubMed ID: 6984404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of biochemical markers to predict the outcome of pregnancies conceived by in vitro fertilization].
    Hauzman E; Murber A; Fancsovits P; Papp Z; Urbancsek J
    Orv Hetil; 2006 Jul; 147(30):1409-20. PubMed ID: 16977779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Establishment of prognosis in threatened abortion. Value of the combined use of diagnostic ultrasound and quantitative determination of chorionic gonadotropin hormone].
    Levi S; Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1973 Mar; 2(2):155-60. PubMed ID: 4807235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.